10 August 2026
ABCL-635 cuts hot flashes 83% at four weeks
Placebo-adjusted drop was 5.3 moderate-to-severe events a day among 92 post-menopausal patients in Phase II.
The full briefing is in the app.
10 August 2026
Placebo-adjusted drop was 5.3 moderate-to-severe events a day among 92 post-menopausal patients in Phase II.
The full briefing is in the app.